Janney Montgomery Scott LLC Grows Stock Position in Maximus, Inc. (NYSE:MMS)

Janney Montgomery Scott LLC increased its position in Maximus, Inc. (NYSE:MMS - Free Report) by 70.5% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 10,145 shares of the health services provider's stock after acquiring an additional 4,196 shares during the period. Janney Montgomery Scott LLC's holdings in Maximus were worth $692,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of MMS. Vanguard Group Inc. boosted its stake in shares of Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after acquiring an additional 205,564 shares during the last quarter. Mackenzie Financial Corp lifted its position in Maximus by 2.0% during the fourth quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock valued at $207,687,000 after purchasing an additional 55,583 shares in the last quarter. Dimensional Fund Advisors LP grew its holdings in Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock valued at $105,001,000 after purchasing an additional 177,075 shares during the period. Fuller & Thaler Asset Management Inc. increased its position in Maximus by 7.4% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock worth $92,188,000 after buying an additional 84,835 shares in the last quarter. Finally, Janus Henderson Group PLC raised its stake in shares of Maximus by 2.0% in the fourth quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider's stock worth $88,546,000 after buying an additional 22,711 shares during the period. Hedge funds and other institutional investors own 97.21% of the company's stock.

Maximus Price Performance

NYSE:MMS traded down $0.38 on Friday, reaching $72.06. 224,629 shares of the company's stock traded hands, compared to its average volume of 572,343. The stock has a 50-day simple moving average of $71.09 and a 200-day simple moving average of $70.94. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The firm has a market cap of $4.06 billion, a PE ratio of 14.33 and a beta of 0.61. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.87.

Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The company had revenue of $1.36 billion for the quarter, compared to analysts' expectations of $1.29 billion. During the same period in the previous year, the firm earned $1.57 EPS. The firm's revenue was up 1.0% compared to the same quarter last year. Equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were paid a $0.30 dividend. This represents a $1.20 annualized dividend and a yield of 1.67%. The ex-dividend date of this dividend was Thursday, May 15th. Maximus's payout ratio is currently 23.86%.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered shares of Maximus from a "buy" rating to a "hold" rating in a report on Thursday, May 15th.

Insider Activity at Maximus

In other news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction dated Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the sale, the director directly owned 14,205 shares of the company's stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.60% of the stock is owned by company insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.